This paper develops a theoretical price competition model, based on the model established in Brekke et al. (2010), in order to analyze the effects of exogenous reference price regulations on pharmaceutical firms' pricing strategies and competitive decisions. Our model establishes demand schedules that represent consumer demand for generic, brand-name, and on-patent drugs under free competition and governmental regulation. Drug equilibrium prices are determined by having firms play a Bertrand game.
Download count: 0